Desktop notifications are on | Turn off
Get breaking news alerts from The Washington Post
Turn on desktop notifications?
The inside track on Washington politics.
*Invalid email address
It’s bigotry as an electoral tool.
He campaigned on the Palin model, and his base will never leave him.
The country’s name is again a toxic word in American politics.
Lawmakers are looking at only half the picture — demand. But what about supply?
Why should anyone not named Bannon stay at the White House?
Who spoke out, and who stood idly by?
Legislators in six states have proposed bills protecting perpetrators of vehicular violence.
Detox without medication-assisted treatment is a death sentence.
The debate over their fate has heated up since Charlottesville; an honest examination must weigh slavery’s role.
He must step up and faithfully execute the health-care law.
In its treatment of Rohingya Muslims, the partly democratic government bears similarities to its autocratic predecessor.
The president's stand on the Confederate hero represents the kind of moral relativism that conservatives usually decry.
How the general’s descendants regard his role in history — and his place atop pedestals.
In 2016, Kushner asserted that his father-in-law was not a racist. What does that mean in 2017?
There’s never been a golden age of free speech at American universities.
Comedy that appeals to young people can be surreal and dark — and completely meaningless.
Is Trump the best presidential golfer? Is Tiger Woods the best golfer ever?
They both hated, coddled and needed reporters.
When your boss can fire you for what you say, are you really free?
Polarization, technology and campus culture are all shifting rapidly. We need to keep up.
Maryland can’t imprison its way out of a drug epidemic.
But what’s frustrating to Arlington’s tree lovers is that such stories are unusual.
Too many elected officials are hit with fines — or worse — for violations.
Ending top-down management is a smart move.
The state’s cumbersome new law distracts from the more difficult and important challenge of lowering prices of patented brand-name drugs.